Literature DB >> 22551535

Biomarker testing in non-small cell lung cancer: to move forward with quality.

Rolf Stahel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22551535     DOI： 10.1007/s12094-012-0802-6

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  6 in total

1.  Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice.

Authors:  L V Sequist; R S Heist; A T Shaw; P Fidias; R Rosovsky; J S Temel; I T Lennes; S Digumarthy; B A Waltman; E Bast; S Tammireddy; L Morrissey; A Muzikansky; S B Goldberg; J Gainor; C L Channick; J C Wain; H Gaissert; D M Donahue; A Muniappan; C Wright; H Willers; D J Mathisen; N C Choi; J Baselga; T J Lynch; L W Ellisen; M Mino-Kenudson; M Lanuti; D R Borger; A J Iafrate; J A Engelman; D Dias-Santagata
Journal:  Ann Oncol       Date:  2011-11-09       Impact factor: 32.976

2.  Two sides of the same coin: EGFR exon 19 deletions and insertions in lung cancer.

Authors:  Katerina Politi; Thomas J Lynch
Journal:  Clin Cancer Res       Date:  2012-02-08       Impact factor: 12.531

3.  Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop.

Authors:  Robert Pirker; Felix J F Herth; Keith M Kerr; Martin Filipits; Miquel Taron; David Gandara; Fred R Hirsch; Dominique Grunenwald; Helmut Popper; Egbert Smit; Manfred Dietel; Antonio Marchetti; Christian Manegold; Peter Schirmacher; Michael Thomas; Rafael Rosell; Federico Cappuzzo; Rolf Stahel
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

Review 4.  The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group.

Authors:  Erik Thunnissen; Keith M Kerr; Felix J F Herth; Sylvie Lantuejoul; Mauro Papotti; Robert C Rintoul; Giulio Rossi; Birgit G Skov; Birgit Weynand; Lukas Bubendorf; Grünberg Katrien; Leif Johansson; Fernando López-Ríos; Vincent Ninane; Włodzimierz Olszewski; Helmut Popper; Sauleda Jaume; Philipp Schnabel; Luc Thiberville; Florian Laenger
Journal:  Lung Cancer       Date:  2011-12-03       Impact factor: 5.705

5.  Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).

Authors:  Pilar Garrido; Javier de Castro; Ángel Concha; Enriqueta Felip; Dolores Isla; Fernando López-Ríos; Luis Paz-Ares; José Ramírez; Julián Sanz; José Javier Gómez
Journal:  Clin Transl Oncol       Date:  2012-05       Impact factor: 3.405

6.  Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010.

Authors:  E Felip; C Gridelli; P Baas; R Rosell; R Stahel
Journal:  Ann Oncol       Date:  2011-05-02       Impact factor: 32.976
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.